Two recent documents—one from the FDA, the other from a commission organized by The Lancet Diabetes & Endocrinology—indicate ...

Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...

As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper ...

I’ve introduced legislation in Florida to expand options for obesity treatment, including public health insurance coverage. | ...

Republicans trying to find billions of Medicaid dollars to pay for tax cuts now say that any reduction in Medicaid spending ...

ROCKVILLE, MD – The Obesity Society (TOS) acknowledges the U.S. Food and Drug Administration's (FDA) recent announcement declaring the end of shortages for Novo Nordisk's Wegovy and Ozempic; two ...

The Department of Social Services remains committed to exploring policy solutions that maximize health outcomes while maintaining fiscal sustainability ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Martin Makary, an author and surgeon at Johns Hopkins University, has appeared frequently on Fox News to talk about health ...